AMBIA
BSX icon

Allen Mooney & Barnes Investment Advisors’s Boston Scientific BSX Stock Holding History

Allen Mooney & Barnes Investment Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$318K Buy
+7,442
New +$404K 0.05% 125

Other funds holding BSX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Allen Mooney & Barnes Investment Advisors's BSX Position: Q2 2026 in Review

Allen Mooney & Barnes Investment Advisors opened a new position in Boston Scientific (BSX) in Q2 2026: 7,442 shares worth $318K. The stake represents 0.05% of the portfolio and ranks #125 among its holdings.

477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Allen Mooney & Barnes Investment Advisors held 7,442 shares of Boston Scientific worth $318K as of Q2 2026.
  • Boston Scientific was a new Allen Mooney & Barnes Investment Advisors position in Q2 2026.
  • Boston Scientific made up 0.05% of Allen Mooney & Barnes Investment Advisors's portfolio in Q2 2026, its #125 holding.
  • 477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Allen Mooney & Barnes Investment Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.